Breaking News

ProPharma Group Acquires PI

By Kristin Brooks | January 15, 2014

Establishes global medical information services firm

ProPharma Group, a compliance services company, has acquired Professional Information Ltd. (PI), a provider of medical information services.  The acquisition creates a global medical information (MI) service organization by combining PI with Advanced Response Management (ARM), a subsidiary of ProPharma Group that provides MI services in the U.S., resulting in a large, global organization exclusively focused on MI.
PI, headquartered in Richmond, UK with an office in Melbourne, Australia, handles medical information inquiries, capturing and reporting adverse events, and medical information-writing services throughout Europe, the Middle East, Africa, and Asia-Pacific, supporting more than 22 languages. ARM provides Medical Information services in the U.S., Canada, and Latin America through its Overland Park, KS offices.
Jeff Hargroves, president of ProPharma Group, said,  “ARM and PI have been successfully providing integrated global MI services for two years in a formal partnership. Our current and future clients will benefit from the seamless integration of data compilation and reporting across the globe. The two companies share a common vision of care for colleagues and clients, and we therefore anticipate a very smooth transition into a single corporate entity.”
Following the acquisition, Rachel Lilley, managing director at PI, and Keith Lilley, director of business development, will continue in their current roles.  “We are very excited to work closely with our U.S. counterparts to expand our current high quality, customer-oriented service globally,” said Ms. Lilley.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks